| Title | MedComm |
| Abbreviation | MedComm |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biochemistry (medical) (Q1); Cell Biology (Q1); Drug Discovery (Q1); Genetics (Q1); Genetics (clinical) (Q1); Immunology and Allergy (Q1); Oncology (Q1) |
| h-index | 41 |
| Overall Rank/Ranking | 978 |
| SCImago Journal Rank (SJR) | 2.469 |
| Impact Score | 8.57 |
| Publisher | John Wiley and Sons Inc |
| Country | United States |
| ISSN | 26882663 |
| Best Quartile | Q1 |
| Coverage History | 2020-2025 |
MedComm is a journal covering the technologies/fields/categories related to Biochemistry (medical) (Q1); Cell Biology (Q1); Drug Discovery (Q1); Genetics (Q1); Genetics (clinical) (Q1); Immunology and Allergy (Q1); Oncology (Q1). It is published by John Wiley and Sons Inc. The overall rank of MedComm is 978. According to SCImago Journal Rank (SJR), this journal is ranked 2.469. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 41. The best quartile for this journal is Q1.
The ISSN of MedComm journal is 26882663. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. MedComm is cited by a total of 3500 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of MedComm is 8.57, which is computed in 2025 as per its definition. MedComm IF is decreased by a factor of 0.63 and approximate percentage change is -6.85% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of MedComm is 8.57. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 8.57 |
| 2023 | 9.20 |
MedComm has an h-index of 41. It means 41 articles of this journal have more than 41 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of MedComm is 26882663. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of MedComm is 978. According to SCImago Journal Rank (SJR), this journal is ranked 2.469. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.469 |
| 2023 | 1.926 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 978 |
| 2023 | 1437 |
MedComm is published by John Wiley and Sons Inc. It's publishing house is located in United States. Coverage history of this journal is as following: 2020-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of MedComm is MedComm. This abbreviation ('MedComm') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biochemistry (medical) (Q1); Cell Biology (Q1); Drug Discovery (Q1); Genetics (Q1); Genetics (clinical) (Q1); Immunology and Allergy (Q1); Oncology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
MedComm latest impact IF is 8.57. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 9.20 (2023) and 8.57 (2024), respectively, in the last 2 years. Moreover, its average IS is 8.89 in the previous 2 years.
The MedComm has an SJR (SCImago Journal Rank) of 2.469, according to the latest data. It is computed in the year 2025. In the past 2 years, this journal has recorded a range of SJR, with the highest being 2.469 in 2024 and the lowest being 1.926 in 2023. Furthermore, the average SJR of the MedComm over the previous 2-year period stands at 8.89.
The latest h-index of the MedComm is 41.
The MedComm is published by the John Wiley and Sons Inc, with its country of publication being the United States.
The MedComm is currently ranked 978 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 2 years, this journal has experienced varying rankings, reaching its highest position of 978 in 2024 and its lowest position of 1437 in 2023.
The standard ISO4 abbreviation for the MedComm is MedComm.
MedComm is classified as a journal that the John Wiley and Sons Inc publishes.
The MedComm encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The MedComm is assigned the following International Standard Serial Numbers (ISSN): 26882663.
The best quartile for the MedComm is Q1 (2024).
The MedComm coverage history can be summarized as follows: 2020-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 9089 | Institute of Electrical and Electronics Engineers Inc. | 55 | 2.19 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Qualitative Research | journal | 1300 | SAGE Publications Ltd | 101 | 6.77 |
| Clinical Medicine and Research | journal | 14921 | Marshfield Clinic | 64 | 1.25 |
| Journal of Geriatric Physical Therapy | journal | 8686 | Lippincott Williams and Wilkins Ltd. | 53 | 1.55 |
| Journal of International Financial Management and Accounting | journal | 1434 | Wiley-Blackwell Publishing Ltd | 50 | 10.53 |
| Journal of Applied Business Research | journal | 26260 | Clute Institute | 33 | 0.17 |
| International Journal of Mathematical Education in Science and Technology | journal | 6477 | Taylor and Francis Ltd. | 45 | 1.82 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Marine Biology Research | journal | 14618 | Taylor and Francis Ltd. | 47 | 1.21 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 8.57 |
| 2023 | 9.20 |
